ACM
GSK icon

Azimuth Capital Management’s GSK GSK Stock Holding History

Azimuth Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,480
Closed -$234K – 279
2019
Q1 		$234K Buy
+4,480
New +$224K 0.02% 267
2018
Q4 		– Sell
-4,000
Closed -$201K – 284
2018
Q3 		$201K Sell
4,000
-120
-3% -$6.1K 0.01% 283
2018
Q2 		$208K Hold
4,120
– – 0.02% 279
2018
Q1 		$201K Sell
4,120
-50,596
-92% -$2.36M 0.01% 280
2017
Q4 		$2.43M Buy
54,716
+8,288
+18% +$383K 0.18% 156
2017
Q3 		$2.36M Sell
46,428
-14,856
-24% -$754K 0.18% 155
2017
Q2 		$3.3M Buy
61,284
+1,037
+2% +$55.3K 0.26% 134
2017
Q1 		$3.17M Buy
60,247
+2,320
+4% +$118K 0.26% 131
2016
Q4 		$2.79M Sell
57,927
-1,311
-2% -$64.8K 0.24% 140
2016
Q3 		$3.19M Buy
59,238
+514
+0.9% +$28.2K 0.28% 118
2016
Q2 		$3.18M Sell
58,724
-1,600
-3% -$84.3K 0.28% 119
2016
Q1 		$3.06M Buy
60,324
+4,748
+9% +$236K 0.29% 113
2015
Q4 		$2.8M Buy
55,576
+4,944
+10% +$252K 0.27% 126
2015
Q3 		$2.43M Sell
50,632
-7,008
-12% -$365K 0.25% 134
2015
Q2 		$3M Buy
57,640
+1,164
+2% +$65.5K 0.29% 114
2015
Q1 		$3.26M Buy
56,476
+27,512
+95% +$1.58M 0.32% 107
2014
Q4 		$1.55M Buy
28,964
+4,368
+18% +$244K 0.16% 161
2014
Q3 		$1.41M Buy
+24,596
New +$1.51M 0.16% 165

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Azimuth Capital Management's GSK Position: Q2 2019 in Review

Azimuth Capital Management sold out of GSK (GSK) in Q2 2019, closing a stake of 4,480 shares — an estimated $234K sold.

Azimuth Capital Management first reported a position in GSK in Q3 2014 and held it in 18 quarters. The position peaked at $3.3M in Q2 2017. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

  • Azimuth Capital Management reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
  • Azimuth Capital Management sold 4,480 GSK shares in Q2 2019, an estimated $234K.
  • Azimuth Capital Management first reported a position in GSK in Q3 2014 and held it in 18 quarters.
  • Azimuth Capital Management's GSK position peaked at $3.3M in Q2 2017.
  • 804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Azimuth Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.